Get started
AbCellera Biologics Inc.AA

AbCellera Biologics Inc.

4.17USDR
−0.13−3.02%
As of today at 18:35 GMT
USD
No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

ABCL trade ideas

ABCL - 20-30% UPSIDE - LONGAll, ABCL is for massively oversold on weekly down so regardless how you feel about the stock (even though price target analysts are WAY higher) this is due for a rip. Not to mention this is a perfect situation for institutions to enter into ABCL at a pretty big discount from fair value etc. I am temporarily waiting next few days watch it extremely closely then entering unless it breaks through the bottom. Feel free to do your DD on ABCL they actually have really good positive pipelines just being held down.
NLong
by DigitalData
AbCellera Biologics Inc 🧙AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes, and analyzes antibody responses to engineer new antibody drug candidates for its partners. If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NLong
by trading_as_bus
ABCL - SARS News - Falling WedgeActually a good chart position / funadmentals iBorrowdesk.com the short fee just doubled from 17 to 35 past 15 minutes. News 15 min ago : www.businesswire.com - Study was the first of its kind to show a neutralizing antibody can decrease SARS-CoV-2 viral shedding and transmission by blocking virus replication in the upper airway - Bamlanivimab moved from first screen to clinical testing in 90 days1 and is the world's first monoclonal antibody specifically developed against SARS-CoV-2 to receive FDA Emergency Use Authorization (EUA)2
NLong
by DigitalData